AbbVie is expected to spend $10.1 billion buying ImmunoGen Inc. by mid-2024, but the pharma firm isn't saying what'll happen to the Waltham company's employees or headquarters.
AbbVie is expected to spend $10.1 billion buying ImmunoGen Inc. by mid-2024, but the pharma firm isn't saying what'll happen to the Waltham company's employees or headquarters.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.